Preventing Secondary BCAA Wasting

The following is a summary of peer-reviewed research by Dunstan, Richard Hugh (2024), published in the Journal of the Australasian College of Nutritional and Environmental Medicine, Vol 43, No 1.  Read the full article

Systemic Failure of Endogenous Synthesis: During severe immunological challenges or intense physical exertion, the body's baseline protein synthesis requirements (3g/kg/day) vastly outpace typical dietary intake (0.8g/kg/day). This creates an absolute physiological reliance on skeletal muscle catabolism to replenish plasma pools. 

Excretory Kinetics and Phenotypic Depletion: Dermal and renal clearance pathways are heavily dominated by six specific High-Demand Amino Acids (HDAAs)—histidine, serine, glycine, lysine, ornithine, and aspartic acid—which constitute up to 72% of total sweat amino acid losses. High-excretor phenotypes (Group C) drain their entire circulating plasma amino acid reservoir every 17 minutes during exertion. 

Secondary Branch-Chain Amino Acid (BCAA) Wasting: Attempting to correct HDAA plasma deficits via targeted muscle proteolysis inadvertently releases lower-demand amino acids into the bloodstream at identical rates. Because these surplus amino acids are not required, they are permanently catabolised for energy or lipogenesis, driving secondary, unnecessary BCAA degradation and severe musculoskeletal wasting.

Clinical endpoint: The primary clinical endpoint is the minimisation of secondary branched-chain amino acid (BCAA) degradation—evidenced by the preservation of lean tissue and structural muscle integrity—by preventing the induction of systemic muscle proteolysis through the targeted replenishment of the six High-Demand Amino Acids (HDAAs).